stockportfolio.pro
Organon & Co. Free Cash Flow 2019–2025
Organon & Co. (OGN) annual free cash flow by fiscal year, computed from SEC filings. Compound growth -24.6%/yr over 6 years.
| Fiscal year | Free Cash Flow | Change (YoY) |
|---|---|---|
| FY 2025 | $538.00M | -29.6% |
| FY 2024 | $764.00M | +39.4% |
| FY 2023 | $548.00M | -17.2% |
| FY 2022 | $662.00M | -66.4% |
| FY 2021 | $1.97B | -3.0% |
| FY 2020 | $2.03B | -30.7% |
| FY 2019 | $2.93B | — |
Source: Organon & Co. SEC filings — cash flow statement (10-K). Refreshed nightly.
See the full picture for Organon & Co.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeOrganon & Co. — frequently asked questions
What is Organon & Co.'s free cash flow?
Organon & Co. (OGN) reported free cash flow of $538.00M for fiscal year 2025, per its SEC filings.
How has Organon & Co.'s free cash flow changed over time?
Between fiscal 2019 and 2025, OGN's free cash flow declined at roughly 24.6% per year (compound annual rate), from $2.93B to $538.00M.
Where does this data come from?
Figures are computed from Organon & Co.'s official SEC filings (cash flow statement (10-K)), refreshed nightly. Not investment advice.